PRNewsWire · November 16, 2026
Novo presents preclinical and human data suggesting a role for amylin and calcitonin receptor activation in preserving bone during weight loss at ObesityWeek®

Get the app for more
Explore stock news, insights and company research.
Get the app → Source: PRNewsWire ↗